Implanet and SeaSpine sign 6-year private label agreement for Jazz spinal devices in US

Implanet entered into a 6-year private label agreement with SeaSpine for distribution of the Jazz portfolio in the U.S. SeaSpine will have exclusive rights to sell Jazz products under its own brand name, including the Jazz Cap implant upon FDA clearance.

“Implanet entered into a 6-year private label agreement with SeaSpine covering distribution of the Jazz® portfolio in the U.S.”orthoworld.com

• 1 source
• orthoworld.comSeaSpine, Implanet Form US Partnership with Jazz Spinal Devices | ORTHOWORLDJulie VetaliceFeb 21, 2019

Summarized from public sources; check the original articles before acting on it.